Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis

Expert Review of Vaccines
Kenneth S RosenthalDaniel H Zimmerman

Abstract

The current status of therapeutic vaccines for autoimmune diseases is reviewed with rheumatoid arthritis as the focus. Therapeutic vaccines for autoimmune diseases must regulate or subdue responses to common self-antigens. Ideally, such a vaccine would initiate an antigen-specific modulation of the T-cell immune response that drives the inflammatory disease. Appropriate animal models and types of T helper cells and signature cytokine responses that drive autoimmune disease are also discussed. Interpretation of these animal models must be done cautiously because the means of initiation, autoantigens, and even the signature cytokine and T helper cell (Th1 or Th17) responses that are involved in the disease may differ significantly from those in humans. We describe ligand epitope antigen presentation system vaccine modulation of T-cell autoimmune responses as a strategy for the design of therapeutic vaccines for rheumatoid arthritis, which may also be effective in other autoimmune conditions.

References

Dec 1, 1977·The Journal of Experimental Medicine·W J CromartieC H Yang
Sep 26, 1991·Nature·T S JardetzkyD C Wiley
Feb 1, 1987·Arthritis and Rheumatism·T T GlantA R Poole
May 1, 1995·European Journal of Immunology·M C BoissierC Fournier
Feb 14, 1998·The Journal of Clinical Investigation·G A SchellekensW J van Venrooij
Jan 1, 1980·Scandinavian Journal of Immunology·T GlantT Szücs
Jul 22, 1999·The New England Journal of Medicine·R A Seder, S Gurunathan
Feb 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Rosetta PedottiLawrence Steinman
Jul 10, 2003·Autoimmunity Reviews·M A M van Boekel, W J van Venrooij
Aug 9, 2003·Springer Seminars in Immunopathology·Berent J PrakkenWillem van Eden
Oct 31, 2003·Critical Reviews in Immunology·Tibor T GlantKatalin Mikecz
Mar 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Berent J PrakkenSalvatore Albani
Apr 3, 2004·Arthritis Research & Therapy·N Fredrik Bäckström, Ulf I H Dahlgren
Sep 10, 2004·The Journal of Allergy and Clinical Immunology·Edwin LiuGeorge S Eisenbarth
Oct 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Hugh McDevitt
Dec 1, 2004·Frontiers in Bioscience : a Journal and Virtual Library·Neena GoelKenneth S Rosenthal
Sep 21, 2005·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Krishnaswamy KannanDonald Kimpel
Jan 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Balik DzhambazovMikael Vestberg
Apr 6, 2006·The Journal of Clinical Investigation·Kristine A KuhnV Michael Holers
Nov 23, 2006·Annals of the Rheumatic Diseases·Alexei von DelwigJohn H Robinson
Jan 27, 2007·Arthritis Research & Therapy·Kutty Selva Nandakumar, Rikard Holmdahl

❮ Previous
Next ❯

Citations

Feb 27, 2017·Rheumatology International·Mary Beth Yu, William H R Langridge
Apr 8, 2020·Journal of Immunology Research·Bin WangGuixiu Shi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.